Oculis Holding AGOCS
13F holders, Q3 2024 (September 30)10holders −1
1new positions
2sold out
$12.26avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Oculis Holding AG (OCS) in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were Pivotal bioVenture Partners Investment Advisor LLC ($19.6M), Aberdeen Group plc ($10.1M) and Nan Fung Group Holdings Ltd ($5.3M).
- Company
- Oculis Holding AG
- CUSIP
- H5870P102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $166K |
| Exits | 2 | $602K |
All 13F filers, Q2 2024 → Q3 2024: 16,000 shares bought and 330,249 shares sold, net −314,249 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Pivotal bioVenture Partners Investment Advisor LLC | 11.61% | No change | 1,595,918 | $19.6M |
| Aberdeen Group plc | 0.02% | Reduce -25.4% | 820,553 | $10.1M |
| Nan Fung Group Holdings Ltd | 4.61% | No change | 436,378 | $5.3M |
| Compagnie Lombard Odier SCmA | 0.02% | No change | 95,750 | $1.2M |
| Bank of America Corp. | 0.00% | Add +6.8% | 18,313 | $225K |
| UBS Group AG | 0.00% | Add +7.7% | 17,777 | $218K |
| Geode Capital Management, LLC | 0.00% | No change | 14,944 | $183K |
| Northern Trust Corp. | 0.00% | New | 13,565 | $166K |
| Dupont Capital Management Corp. | 0.00% | No change | 4 | $49 |
| JPMorgan Chase & Co. | 0.00% | No change | 1 | $12 |
"% of holder's portfolio" is OCS's weight in each manager's 13F, not the share of Oculis Holding AG the manager owns.